Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,479 stories, page 456 of 692

Advanced search

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

The Data Problem Behind Prescription Drug Waste

Pharmaceutical CommerceOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Gold Medal-Winning Olympic Icon Dies at 50

The Daily BeastOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Allergy medication recall warns of life-threatening reaction

Rolling OutOriginal source

🇨🇦Jul 22Researchgenomecanada.caTier 2 · Direct publisher

Genome Canada appoints new Board members and SIAC Chair

Genome CanadaOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Bayer, Kairos Pharma Collaborate to Boost Xofigo Effectiveness in Metastatic Prostate Cancer

Contract PharmaOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Single Use Support speeds design cycle for pharma

Siemens NewsroomOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Investors brace for West Pharmaceutical earnings after Q1 beat By Investing.com

Investing.comOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Pharma tries to tamp down broad China restrictions

STATOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Mentari adds $200M to migraine mission; Royalty’s latest ATTR-CM deal

Endpoints NewsOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Samsung Biologics: geographic diversification is a sound business decision

Pharmaceutical TechnologyOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma Chief Development Officer Gary S. Jacob Increases Shareholding with Open-Market Purchase

Quiver QuantitativeOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Randomised Controlled Trial of Preventive Treatment of Latent Tuberculosis Infection in Patients with Diabetes Mellitus

CORDISOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Drug Optimisation in LMICs of Pregnant HIV women and their Infants: temporary switch to CAB/RPV long acting injections

CORDISOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Noise and/or ultrafine particulate matter induced cerebral and cardiovascular damage: novel insights from experimental and epidemiological brain-heart axis biomarkers and computational models

CORDISOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Building multidisciplinary evidence to support Integrating Malaria VACcine with Seasonal malaria chemoprevention in West Africa

CORDISOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments

CORDISOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Biotech's takeover boom may be running out of buyers

Yahoo Finance UKOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Non-tArgeted foRensic multidisCiplinary platfOrm for inveStigatIon of drug-related fatalitieS

CORDISOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Royalty pens $425M deal for slice of AstraZeneca ATTR drug sales

Fierce BiotechOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Pharma Horizons: Nitrosamines

European Pharmaceutical ReviewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Rapid microbiology in history: a timeline to USP

European Pharmaceutical ReviewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Fugitive doctor on run for 21 years was living as an L.A. biotech executive

KGET.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

The biotech bi-weekly: multiomics, human cell-based research, next-gen cell recovery and biomarker development

BioTechniquesOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Redwire opens research and microgravity payload development facility

Electronics WeeklyOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Mid-Year Check-In: Has Prior Auth Reform Delivered?

Pharmaceutical CommerceOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Here's Why You Should Add Savara Stock to Your Portfolio Now

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply

CNBCOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Biotech Pre-Market Pulse: LABT, INM, PMI Drives Early Market Momentum

RTTNewsOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech (TRIB) Announces Reverse ADS Split to Meet Nasda

GuruFocusOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Evercore ISI initiates Tenax Therapeutics stock coverage with outperform rating

Investing.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

What would 200% US tariffs on generic drugs mean for China’s pharmaceutical industry?

South China Morning PostOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge

Fierce BiotechOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Haisco Pharmaceutical reports new STAT6 inhibitors

BioWorld NewsOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Single Use Support speeds design cycle for pharma

Siemens NewsroomOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

The Hollowing Out of America’s Medicine Cabinet

Coalition For A Prosperous AmericaOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Jiangxi Synergy Pharmaceutical Co. Ltd. Class A – SZSE:300636

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech (TRIB) Adjusts ADS Ratio to Meet Compliance Requ

GuruFocusOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A – SSE:600513

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Biotech IPOs Surge 55% in 2026, Outpacing Market Rivals

Briefs FinanceOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

FDA opens door for Uganda’s cancer drug

Uganda ObserverOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech partners with Latch Medical on metabolic health tech

Investing.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

U.S. FDA panel to review 7 peptides amid growing popularity

CBCOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Vytrus Biotech SA – TRADEGATE:V5P

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech plans 1-for-30 reverse ADS split

Investing.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia

The Manila TimesOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech (NASDAQ: TRIB) plans equity-backed Latch Medical tie-up in CGM-guided drug delivery

Stock TitanOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech (Nasdaq: TRIB) sets 1-for-30 reverse ADS split

Stock TitanOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

FDA accepts BridgeBio's NDA for encaleret to tr...

PluangOriginal source

🇨🇦Jul 22Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

HeartSine® Samaritan® PAD SAM 350P/SAM 360P/SAM 500P

Stryker has identified a limited number of HeartSine samaritan PAD devices that were distributed wit...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 22Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

DCA Vantage® HbA1c (DX Claim)

Siemens Healthineers has confirmed through customer complaint investigation and internal testing tha...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

LB Pharmaceuticals Expects Results From 460-Patient Trial in 1H 2027

Stock TitanOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Crystalys mines $130M series B to push gout drug through phase 3

Fierce BiotechOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia

Arrowhead Pharmaceuticals, Inc.Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Biotech Growth Trust PLC – TURQUOISE:BIOGL

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

MHRA approves first HFA-152a propellant pMDI inhalers

European Pharmaceutical ReviewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Rep. Buchanan Celebrates Passing Of Bill Cracking Down On Animal Testing

Floridian PressOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech's Wearable Sensors May Guide Drug Delivery

Stock TitanOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia

Business WireOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For

StockStoryOriginal source